Educational Resources

PBL Blog

Biologics, In Vivo Services, Medical Device, News, Pharmaceuticals | May 3, 2022

Pacific BioLabs announces the launch of In Vitro Services

Pacific BioLabs (PBL) is pleased to announce the launch of In Vitro Services offering in vitro, cell-based assays supporting the pharmaceutical, biopharma, and medical device industries. The addition of this group to the PBL testing portfolio increases upon and is complimentary to well-established testing capabilities in our Microbiology, Analytical/Bioanalytical, and In Vivo departments.

Cell-based assays fall into several categories and are often used as tools to explore initial biological responses to a variety of stimuli. For example, the biopharmaceutical industry may utilize cell-based assays at early stages of product development in establishing product safety/potency whereas the medical device industry may use the same assays to evaluate the cytotoxic potential of leachable/extractable materials in a new device proposed for human use.  Further, industry-based initiatives are underway to transition from traditional high-dose animal studies to an approach that is based on an understanding of cellular responses using well-designed in vitro, cell-based assays.

The In Vitro Services group is led by highly experienced scientists with a depth of subject matter expertise that enables characterization of an array of biological activities utilizing both stand alone and integrated assay endpoints/readouts. Contact PBL to discuss your in-vitro, cell-based assay needs.


  • Cell Bank and Cell Culture Core – Primary and Immortalized Cell Lines
  • Cytotoxicity Assays
  • Proliferation Assays
  • Apoptosis Assays
  • Hemolysis Assays
  • Angiogenesis Assays
  • Reporter Assays
  • Cytokine Release Assays
  • Ex Vivo Animal Primary Cells
  • Custom Method Development and Transfer
  • Animal Model Alternatives



Pacific BioLabs